← Back to Search

Feedback-Based Learning for Developmental Language Disorder

N/A
Recruiting
Led By Yael Arbel, PhD
Research Sponsored by MGH Institute of Health Professions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Must not have
Hearing loss or other known neurological deficits, or diagnoses (e.g., Attention deficit disorder, Autism, Traumatic Brain Injury)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during each learning task
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to optimize feedback-based learning in children with DLD by manipulating timing & level of learner's involvement in error correction. Aims: determine effect of timing on learning & compare learning when feedback promotes active self-correction vs passive exposure to corrections.

Who is the study for?
This trial is for English-speaking children aged 8-12 with developmental language disorder (DLD), having an IQ score above 70 and specific language test scores. It excludes those with hearing loss, neurological issues like ADHD or autism, traumatic brain injury, or color blindness.
What is being tested?
The study tests how different types of feedback affect learning in children with DLD. It varies the timing (immediate vs delayed) and involvement (active self-correction vs passive exposure to corrections) during tasks designed to enhance language skills through tailored feedback.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional side effects are not applicable. However, there may be varying levels of frustration or fatigue experienced by participants due to the nature of the learning tasks.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have hearing loss or a neurological condition like ADD, Autism, or TBI.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after learning task
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after learning task for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Accuracy (percent correct) on a two-choice paired associate test 1 week after the task
Accuracy (percent correct) on a two-choice paired associate test immediately after the task
FRN amplitude
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Children with developmental language disorderExperimental Treatment6 Interventions

Find a Location

Who is running the clinical trial?

MGH Institute of Health ProfessionsLead Sponsor
16 Previous Clinical Trials
1,901 Total Patients Enrolled
Yael Arbel, PhDPrincipal InvestigatorMGH Institute of Health Professions

Media Library

Declarative learning with delayed feedback Clinical Trial Eligibility Overview. Trial Name: NCT05678634 — N/A
Language Developmental Disorders Research Study Groups: Children with developmental language disorder
Language Developmental Disorders Clinical Trial 2023: Declarative learning with delayed feedback Highlights & Side Effects. Trial Name: NCT05678634 — N/A
Declarative learning with delayed feedback 2023 Treatment Timeline for Medical Study. Trial Name: NCT05678634 — N/A
~92 spots leftby Oct 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top